Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|March 26, 2013
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysisNitin Ohri, Madhur K Garg, Santiago Aparo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2018
The impact of dietary regimen compliance on outcomes for HNSCC patients treated with radiation therapyRafi Kabarriti, Amanda Bontempo, Maria Romano, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2009
Change in seroma volume during whole-breast radiation therapyRajiv Sharma, Marnee Spierer, Subhakar Mutyala, et al.
JAMA Network Open|September 25, 2020
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New YorkRafi Kabarriti, N Patrik Brodin, Maxim I Maron, et al.
Cureus|March 23, 2019
Origin of Locoregional Recurrences After Definitive Intensity-modulated Radiation Therapy (IMRT) for Laryngeal Cancer Determined Based on Follow-up PET/CT ImagingRafi Kabarriti, N Patrik Brodin, Sadia Ahmed, et al.
The British Journal of Radiology|December 13, 2016
Fractionated stereotactic radiation therapy for brain metastases: a systematic review with tumour control probability modellingSujith Baliga, Madhur K Garg, Jana Fox, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2004
Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiationMadhur K Garg, Paul Weiss, Anand K Sharma, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2014
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancerNitin Ohri, Bilal Piperdi, Madhur K Garg, et al.
Radiation Research|July 4, 2014
An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor modelYujo Kawashita, Niloy J Deb, Madhur K Garg, et al.
Radiation Oncology (London, England)|January 22, 2021
Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancerN Patrik Brodin, Rafi Kabarriti, Clyde B Schechter, et al.
Pageof 7